Panoxyl Acne Banishing Body (spray)

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the treatment of acne. It effectively clears blemishes and helps prevent future breakouts.

There are no teratogenic or nonteratogenic effects mentioned associated with this drug.

Dosage and Administration

Healthcare professionals are advised to ensure that the skin is thoroughly cleaned prior to the application of this product. The recommended application involves covering the entire affected area with a thin layer. This should be done one to three times daily, depending on the patient's needs and the physician's guidance.

To minimize the risk of excessive drying of the skin, it is recommended to initiate treatment with one application per day. Based on the patient's response, the frequency may be gradually increased to two or three times daily as necessary or as directed by a healthcare provider.

In cases where bothersome dryness or peeling occurs, it is advisable to reduce the frequency of application to once daily or every other day to alleviate these symptoms.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes, as this product may cause irritation. The formulation is flammable; therefore, it should be kept away from fire or flame. Additionally, the contents are under pressure; puncturing or incinerating the container is strictly prohibited. Storage should not exceed temperatures of 120°F to ensure safety and efficacy.

General precautions should be observed, particularly regarding the potential for skin irritation and dryness. The likelihood of these adverse effects increases when this product is used concurrently with other topical acne medications. To minimize the risk of irritation, it is recommended that only one topical acne medication be utilized at a time.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Side Effects

Patients using this product should be aware of several important warnings and potential adverse reactions. This product is intended for external use only, and care should be taken to avoid spraying it in the eyes. It is flammable; therefore, it should be kept away from fire or flame. Additionally, the contents are under pressure, and users are advised not to puncture or incinerate the container. It is also important to store the product at temperatures not exceeding 120°F.

During the use of this product, skin irritation and dryness may occur, particularly if another topical acne medication is used concurrently. To minimize the risk of irritation, it is recommended that only one topical acne medication be used at a time.

In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Panoxyl Acne Banishing Body (spray) (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure the safety of both the mother and the developing fetus.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no information available regarding renal impairment, including dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of specific guidance when treating patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous evaluation and appropriate interventions should be implemented based on the clinical presentation and severity of symptoms.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional prior to use. Skin irritation and dryness may be exacerbated when used concurrently with other topical acne medications. In cases of irritation, it is recommended to limit the use to one topical acne medication at a time.

No additional information is available regarding nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. Instruct patients that if the medication is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Additionally, it is important to inform patients about the potential for skin irritation and dryness. Patients should be cautioned that using this medication concurrently with another topical acne treatment may increase the likelihood of these side effects. If patients experience irritation, they should be advised to use only one topical acne medication at a time to minimize the risk of adverse effects.

Storage and Handling

The product is supplied in accordance with the following specifications. It should be stored at a temperature range of 20°C to 25°C (68°F to 77°F), adhering to the guidelines set forth by USP Controlled Room Temperature.

Proper storage conditions are essential to maintain the integrity of the product. It is recommended to keep the product in its original container to protect it from environmental factors. Special handling requirements should be observed to ensure optimal quality and efficacy.

Additional Clinical Information

The medication is administered topically, with a recommended application of a thin layer to the entire affected area one to three times daily. Patients should begin with one application daily and may gradually increase to two or three times daily as needed or directed by a healthcare provider. In cases of bothersome dryness or peeling, it is advised to reduce the frequency to once daily or every other day.

Clinicians should counsel patients to consult a health professional if they are pregnant or breastfeeding before use. Additionally, patients should be informed that the likelihood of skin irritation and dryness increases when using another topical acne medication concurrently. Therefore, it is recommended to use only one topical acne treatment at a time to minimize the risk of irritation.

Drug Information (PDF)

This file contains official product information for Panoxyl Acne Banishing Body (spray), including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)